JAMES F YOUNG Insider Trading
Get free email notifications about insider trading for JAMES F YOUNG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES F YOUNG. JAMES F YOUNG is a President, R&D in MEDIMMUNE INC /DE ($MEDI) and a Director in NOVAVAX INC ($NVAX).
Address: 35 WEST WATKINS MILL ROAD GAITHERSBURG 20878 MD
Companies in which JAMES F YOUNG is an Insider
MEDIMMUNE INC /DE
Trading Symbol: MEDIIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JAMES F YOUNG: President, R&D
Holdings: 0 shares
Latest Transaction: Mar 10 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NOVAVAX INC
Trading Symbol: NVAXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JAMES F YOUNG: Director
Holdings: 20,000 shares
Current Value: $26,200
Latest Transaction: Jun 22 2021
$NVAX Market Capitalization: $355.26M
$NVAX Previous Close: $1.31
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JAMES F YOUNG
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | A | 0.00 | 1,400 | 0 | 1,400 | |
Jun 22 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | A | 179.89 | 2,600 | 467,714 | 2,600 | |
Mar 25 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | M | 3.99 | 37,500 | 149,438 | 0 | |
Mar 25 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | M | 27.60 | 10,000 | 276,000 | 0 | |
Mar 25 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | M | 46.00 | 10,000 | 460,000 | 0 | |
Mar 25 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Buy | M | 3.99 | 37,500 | 149,438 | 57,500 | 20 K to 57.5 K (+187.50 %) |
Mar 25 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Buy | M | 27.60 | 10,000 | 276,000 | 20,000 | 10 K to 20 K (+100.00 %) |